Synthesis and photodynamic properties of 5-ALA/g-C3N4@1 supramolecular photosensitizer with potential application in chronic hepatitis B treatment
摘要
The development of activatable nanoplatforms to enhance diagnostic and therapeutic performance while minimizing side effects is of great significance in treatment of chronic hepatitis B (CHB). Here, we report a novel nanomaterial composed of graphitic carbon nitride (g-C3N4) and 5-aminolevulinic acid (5-ALA), onto which our newly synthesized compound 1 is loaded, forming 5-ALA/g-C3N4@1. This nanomaterial is highly pH-sensitive and can rapidly degrade in mildly acidic environments, enabling the release of its loaded photosensitizer and compound 1, exhibiting characteristics such as fluorescence recovery and increased singlet oxygen generation. We evaluated the bioactivity of this novel composite material and explored its mechanisms of action. The effect of 5-ALA/g-C3N4@1 on the levels of HBV DNA, HBsAg and HBeAg was evaluated by treatment of HepG2.2.15 cells with the system. Our results suggest that the system can effectively inhibit HBV replication for the treatment of CHB. This work presents a novel photosensitive carrier with excellent biocompatibility and therapeutic efficacy, offering new insights into CHB research.